Most prostate cancers (PC) are currently found on the basis of an elevated PSA, although
this biomarker has only moderate accuracy. Histological confirmation is traditionally …

Background The highly intra-tumoral heterogeneity and complex cell origination of prostate
cancer greatly limits the utility of traditional bulk RNA sequencing in finding better biomarker …

Abstract Measurement of serum Prostate Specific Antigen (PSA) level is useful to detect
early prostate cancer. PSA-screening may reduce the mortality rate from prostate cancer, but …

Regarding the development of new antineoplastic agents, with a view to assess the
selective antitumoral potential which aims at causing irreversible damage to cancer cells …

This article reviews the clinical applications of current ultrasound elastography methods in
non-hepatic conditions including thyroid nodules, prostate cancer, chronic kidney disease …

Cervical cancer, a potentially preventable disease, has its main aetiology in infection by high
risk human papillomavirus (HR-HPV). Approaches to improving cervical cancer screening …

The present invention provides glycan-interacting antibodies useful in the treatment and
prevention of human disease, including cancer. Such glycan-interacting antibodies include …

A61K47/50—Medicinal preparations characterised by the non-active ingredients used, eg
carriers or inert additives; Targeting or modifying agents chemically bound to the active …

Traditional hand-held ultrasound probe has some limitations in prostate biopsy. Improving
the localization and accuracy of ultrasound probe will increase the detection rate of prostate …

Precise dose delivery to malignant tissue in radiotherapy is of paramount importance for
treatment efficacy while minimizing morbidity of surrounding normal tissues. Current …